Kalina Rajaobelina

Kalina Rajaobelina

Auto-generated profile, based on publicly available information

Kalina Rajaobelina

Inserm, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Univ. Bordeaux, Bordeaux, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2015 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
KRKalina Rajaobelina
Kalina Rajaobelina
ACAudrey Cougnard-Gregoire
Audrey Cougnard-Gregoire
CDCecile Delcourt
Cecile Delcourt
HGHenri Gin
Henri Gin
PBPascale Barberger-Gateau
Pascale Barberger-Gateau
VRVincent Rigalleau
Vincent Rigalleau
Advanced glycation end products are involved in the vascular complications of diabetes, in chronic kidney disease, and in the aging process. Their accumulation in the elderly people, as reflected by skin autofluorescence (sAF), may be a marker of metabolic memory. We aimed to examine the association of sAF with glycemic and renal status 10 years earlier in older persons. In retrospective cohort study, 328 elderly community dwellers aged of 75 years and over had sAF measurement 10 years after their inclusion in the Three-City cohort. Fasting plasma glucose and serum creatinine were measured at baseline and at 10-year follow-up. In 125 participants, HbA1c was available at these two times. Associations between sAF and the glycemic and renal status 10 years before were analyzed by multivariate linear regression adjusted for age, sex, hypertension, body mass index, hypertriglyceridemia, and smoking. Participants were 82.4 (standard deviation = 4.1) years on average, and their mean sAF was 2.8 (standard deviation = 0.7) arbitrary units (AU). After adjustment, sAF was higher in participants with long-standing diabetes (+0.38 AU, p = .01) or chronic kidney disease (+0.29 AU, p = .02) compared with healthy participants. sAF was related to fasting plasma glucose (+1 mmol/L associated with +0.08 AU, p = .01) and HbA1c (+1% associated with +0.15 AU, p = .03) 10 years earlier, but not to the current fasting plasma glucose (p = .82) and HbA1c (p = .32). sAF was also related to the distal and current estimated glomerular filtration rates (p = .002 and .004, respectively). sAF reflects glycemic and renal status 10 years before, supporting its value as a marker of metabolic memory in the elderly people.

1 September 2016 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
FVFritz-Line Vélayoudom-Céphise
Fritz-Line Vélayoudom-Céphise
KRKalina Rajaobelina
Kalina Rajaobelina
CHCatherine Helmer
Catherine Helmer
SNSovanndany Nov
Sovanndany Nov
EPEmilie Pupier
Emilie Pupier
VRVincent Rigalleau
Vincent Rigalleau
We aimed to analyze the relationships between skin autofluorescence (SAF) and incident macrovascular events and renal impairment after 4 years of follow-up in patients with type 1 diabetes (T1D). Two hundred and forty-three patients (51.2 ± 16.7 years old) with T1D participated. SAF was measured by AGE-Reader-TM at inclusion. Macrovascular events (MVE), estimated glomerular filtration rate (eGFR) and urinary albumin excretion rate (AER) were recorded then and 4 years later. Multivariate logistic regression was used to analyze the relationships between SAF and incident MVE and renal profile 4 years later. Patients with incident MVE had a higher SAF (p = 0.003). SAF predicted incident MVE after adjustment for age, sex, body mass index, tobacco, diabetes duration, hypertension, HbA1c, AER, eGFR (OR 4.84 [95 % CI 1.31–17.89], p = 0.018). However, this relation was no longer significant after adjustment for history of MVE. An inverse relation was found between SAF and incident eGFR (p = 0.0001). Patients with incident eGFR <60 ml/min/1.73 m2 had a SAF higher than patients with normal eGFR. After adjustment for the previous criteria, SAF remained associated with the risk of impaired incident eGFR (OR 7.42 [95 % CI 1.59–34.65], p = 0.018). No relation was found between SAF and increased AER 4 years later. SAF predicts MVE in patients with T1D, adjusted for cardiovascular risk factors but the most powerful predictive factor remains history of MVE. SAF also predicts eGFR impairment, adjusted for initial AER and renal function. SAF could be a useful non-invasive tool for estimating risk of cardiovascular or renal impairment in patients with T1D.

27 May 2016 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
KRK Rajaobelina
K Rajaobelina
BFB Farges
B Farges
SNS Nov
S Nov
EME Maury
E Maury
FCFl Cephise‐Velayoudom
Fl Cephise‐Velayoudom
VRV Rigalleau
V Rigalleau
Objective: Advanced glycation end products (AGEs) are involved in diabetes complications. We aimed to investigate whether the accumulation of AGEs measured by skin autofluorescence (sAF) was associated with signs of diabetic peripheral neuropathy and to sensitivity, pain, motor and autonomic function 4 years later in patients with type 1 diabetes.Methods: At baseline, 188 patients (age 51 years, diabetes duration 22 years) underwent skin autofluorescence measurement using the AGE Reader. Four years later, signs of diabetic peripheral neuropathy were defined as the presence of neuropathic pain and/or feet sensory loss or foot ulceration. Neurological tests were systematically performed: vibration perception threshold by neuroesthesiometry, neuropathic pain by the Douleur Neuropathique en 4 Questions score, muscle strength by dynamometry and electrochemical skin conductance. Multivariate analyses were adjusted by age, sex, height, body mass index, tobacco, HbA1c, diabetes duration, estimated glomerular filtration rate and albumin excretion rate.Results: At the 4‐year follow‐up, 13.8% of patients had signs of diabetic peripheral neuropathy. The baseline sAF was higher in those with signs of diabetic peripheral neuropathy (2.5 ± 0.7 vs 2.1 ± 0.5 arbitrary units (AU), p < 0.0005). In the multivariate analysis, a 1 SD higher skin autofluorescence at baseline was associated with an increased risk of signs of neuropathy (OR = 2.68, p = 0.01). All of the neurological tests were significantly altered in the highest quartile of the baseline sAF (>2.4 AU) compared with the lowest quartiles after multivariate adjustment.Conclusion: This non‐invasive measurement of skin autofluorescence may have a value for diabetic peripheral neuropathy in type 1 diabetes and a potential clinical utility for detection of diabetic peripheral neuropathy. Copyright © 2016 John Wiley & Sons, Ltd.

18 July 2017 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
KRKalina Rajaobelina
Kalina Rajaobelina
CHCatherine Helmer
Catherine Helmer
FVFritz‐Line Vélayoudom‐Céphise
Fritz‐Line Vélayoudom‐Céphise
SNSovanndany Nov
Sovanndany Nov
BFBlandine Farges
Blandine Farges
VRVincent Rigalleau
Vincent Rigalleau

9 February 2017 in Critical Care
Verified
Journal Article
Open access
PDF file
ALAurelie Lavielle
Aurelie Lavielle
SRSebastien Rubin
Sebastien Rubin
ABAlexandre Boyer
Alexandre Boyer
KMKarine Moreau
Karine Moreau
KRKalina Rajaobelina
Kalina Rajaobelina
VRVincent Rigalleau
Vincent Rigalleau

29 March 2017 in Diabetes & Metabolism
Verified
Journal Article
Closed access
PDF file
GLG. Lapeyre
G. Lapeyre
ACA. Cougnard-Grégoire
A. Cougnard-Grégoire
Marie Nöelle DelyferMarie Nöelle Delyfer
Marie Nöelle Delyfer
CDCécile Delcourt
Cécile Delcourt
SHS. Hadjadj
S. Hadjadj
VRVincent Rigalleau
Vincent Rigalleau